Riskpilot← Back to searchSign inGet full accessVrejlev Bioenergi P/S
KASActiveCVR 37303240Vrejlev Energipark 11Manufacture of gas · NACE 3521Est. 20153 employees
Revenue 2024
DKK -31K
-1311% vs 2023
EBITDA margin
100.0%
-306% vs 2023
Equity ratio
66.2%
Financial strength
Net profit 2024
DKK -24K
-371% vs 2023
| Revenue | DKK -31K | -1311% |
| EBITDA | DKK -31K | -306% |
| Net profit | DKK -24K | -371% |
| Total assets | DKK 2,7M | -19% |
| Equity | DKK 1,8M | -36% |
| Employees | 3 | — |
Legal name
Vrejlev Bioenergi P/S
CVR number
37303240
Legal form
Kommanditaktieselskab/Partnerselskab
NACE code
3521 · Manufacture of gas
Founded
15. december 2015
Share capital
DKK 500.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen eller af bestyrelsen i fællesskab.
Company purpose
Virksomhedens formål er at stå for projektering, anlæg og drift af biogasanlæg samt anden dermed beslægtet virksomhed.
Address
Vrejlev Energipark 11
Email
kontor@vmlandbrug.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5.077 | 11.028 | 50.737 | 3 | -31 |
| Staff expenses | -1.224 | -1.705 | -2.997 | -10 | -0 |
| EBITDA | 3.853 | 9.323 | 47.739 | -8 | -31 |
| Depreciation & amort. | -4.642 | -5.015 | -2.753 | -0 | -0 |
| EBIT | -788 | 4.308 | 44.987 | -8 | -31 |
| Net financials | -650 | -754 | -3.539 | 16 | 7 |
| Profit before tax | -1.438 | 3.554 | 41.447 | 9 | -24 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -1.438 | 3.554 | 41.447 | 9 | -24 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 60.585 | 59.860 | 27.644 | 3.358 | 2.726 |
| Equity | 16.819 | 20.373 | 13.820 | 2.829 | 1.805 |
| Long-term debt | 20.416 | 18.052 | 0 | 0 | 0 |
| Short-term debt | 23.349 | 21.436 | 13.824 | 529 | 920 |
| Total debt | 43.765 | 39.487 | 13.824 | 529 | 920 |
EBITDA margin
-3086200.0%
This company
15.8%
Market median
-19533011% vs market
20202024
Equity ratio
66.2%
This company
38.2%
Market median
+73% vs market
20202024
Return on equity
-1.3%
This company
18.4%
Market median
-107% vs market
20202024
Net profit margin
-2368500.0%
This company
8.1%
Market median
-29240841% vs market
20202024
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20202024
Debt / equity
0.51×
This company
0.62×
Market median
+18% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TR Management | Management | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2015 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2015 | |
| Individual | 50–66.65% | 50–66.65% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vrejlev Bioenergi P/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Risager Kjær | Management | 0 companies |
| Grete Kjær | Board of Directors | 0 companies |